Sodium Oxybate
Lumryz, Xyrem
NADAC/unit
N/A
No Shortage
Tier 1: 43.2%
PA Req: 180.2%
2 Manufacturers
2 ANDAs
Active Shortages
2025-12-29 Discontinuation of the manufacture of the drug, Amneal Pharmaceuticals
Generic Manufacturers
AMNEAL PHARMACEUTICALS LLCASCENT PHARMACEUTICALS INCAVADEL CNS PHARMACEUTICALS LLCJAZZ PHARMACEUTICALS INC
Explore in the Ecosystem
Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.
